a Screening for colorectal cancer (CRC) is associated with reduced CRC mortality, but low screening rates have been reported in several settings. The aim of the study was to assess predictors of low CRC screening in Switzerland. A retrospective cohort of a random sample of 940 patients aged 50-80 years followed for 2 years from four Swiss University primary care settings was used. Patients with illegal residency status and a history of CRC or colorectal polyps were excluded. We abstracted sociodemographic data of patients and physicians, patient health status, and indicators derived from RAND's Quality Assessment Tools from medical charts. We defined CRC screening as colonoscopy in the last 10 years, flexible sigmoidoscopy in the last 5 years, or fecal occult blood testing in the last 2 years. We used bivariate and multivariate logistic regression analyses. Of 940 patients (mean age 63.9 years, 42.7% women), 316 (33.6%) had undergone CRC screening. In multivariate analysis, birthplace in a country lower CRC screening rates. Obesity, overweight, birthplace outside of Western Europe and North America, and male sex of the physician in charge were associated with lower CRC screening rates in Swiss University primary care settings. Physician perception of obesity and its impact on their recommendation for CRC screening might be a target for further research.
Background
According to the WHO, colorectal cancer (CRC) is the fourth leading cause of cancer death worldwide. CRC screening using biennial fecal occult blood testing (FOBT) has been shown to reduce CRC-related mortality by about 14% (Heresbach et al., 2006) . Screening colonoscopy every 10 years, flexible sigmoidoscopy every 5 years, or annual FOBT have been recommended by US Guidelines (US Preventive Services Task Force, 2008) and a European Panel (Arditi et al., 2009) for patients older than 50 years of age. Several studies also support the cost effectiveness of CRC screening (Pignone et al., 2002; Sekiguchi et al., 2012) . However, reported screening rates remain around 55% in the USA (American Cancer Society, 2011; Fagan et al., 2011a) and around 45% in European countries (Pox et al., 2007) .
For a better understanding of these low rates, recent studies have examined the factors associated with CRC screening. Socioeconomic factors such as white ethnicity, male sex, lower age, higher education level and higher household income, and insurance coverage were found to be associated with higher CRC screening rates in several studies in the USA and Canada (Wee et al., 2005; Zimmermann et al., 2006; Sewitch et al., 2007; Phillips et al., 2013) . Whereas the presence of a chronic condition increased the odds for CRC screening in one study (Sewitch et al., 2007) , no association with the number of chronic conditions was found in another (Phillips et al., 2013) . A recent review on the relationship between obesity and cancer screening found a complex pattern of positive and negative associations between CRC screening and weight status throughout the literature (Fagan et al., 2011b) . Several studies have found that annual influenza vaccine was associated with higher CRC screening rates (Zimmermann et al., 2006; Sewitch et al., 2007) . The main reasons not to perform FOBT screening were patient unawareness and physicians not recommending it (Wee et al., 2005) .
Outside of Northern America, publications on correlates of CRC screening are rare. A recent Spanish study found higher education level, periodic screening for breast and cervical cancer in women, and knowledge of CRC and CRC screening to increase odds for initial participation in a population-based screening program (García et al., 2011) . One study from Hong Kong found that physician factors such as experience, academic appointment, and agreement with CRC screening were associated with higher screening rates (Wong et al., 2009) . However, we found no studies assessing the factors associated with CRC screening in European countries without a population-based screening program, such as Switzerland.
The aim of this study was to assess patient and physician factors associated with lower rates of CRC screening in University primary care settings in Switzerland, a country without a population-based screening program.
Methods

Study design and patients
The study design has been published previously (Collet et al., 2011) . Briefly, this retrospective cohort study aimed to assess the quality of preventive care and control of cardiovascular risk factors, and included a random sample of all patients aged 50-80 years followed up by primary care physicians in four Swiss University primary care settings in Basel, Geneva, Lausanne, and Zurich during 2005 and 2006 . We limited the sample to this age to have a high enough prevalence of examined preventive indicators and eligibility for cancer screening. From the initial random sample of 1889 patients, we excluded patients whose medical charts could not be found (54), patients with emergency visits or nurse appointment only (125), and those followed up in specialized clinics only (117) or for less than 1 year (591), because of a possible lack of adequate time to provide preventive care (Appendix Fig. 1 ). For this study, we also excluded 12 patients known for CRC or colorectal polyps at the beginning of the review period, as the focus was to assess cancer screening in average-risk patients and not cancer follow-up. In addition, we excluded 50 patients with irregular residency status, as insurance coverage is not guaranteed for these patients. The final sample consisted of 940 abstracted medical charts. A similar sample size was used in previous studies on quality of care based on chart abstraction (Kerr et al., 2003; Asch et al., 2004) . The Institutional Review Board approved the study protocol at each site.
Chart abstraction
On the basis of previous studies on factors associated with CRC screening (Wee et al., 2005; Zimmermann et al., 2006; Wong et al., 2009) , we examined the following indicators: patient demographic characteristics, including age, sex, civil status, birthplace, and occupation, and characteristics of the physician in charge (defined as the physician with whom the patient had the most visits over the review period), including sex, position, and number of visits. BMI was calculated as reported, body weight in kilograms divided by squared height in meters, or directly abstracted from the medical chart. As a surrogate to patient health status, we calculated the Charlson combined age-comorbidity index (Charlson et al., 1994; De Groot et al., 2003) from reported comorbid conditions and the patient's age. As this index only captures a limited list of conditions that have a potential impact on survival, we abstracted the number of prescribed medications over the 2-year review period.
As described previously (Collet et al., 2011) , patient data were abstracted from medical charts by trained medical students using a questionnaire form similar to previous studies (Kerr et al., 2003; McGlynn et al., 2003; Asch et al., 2004) . The questionnaire assessed the 33 selected indicators for chronic and preventive care derived from RAND's Quality Assessment Tool System (McGlynn et al., 2003) , as well as other covariates (demographics, comorbid conditions) on the basis of the chart abstraction form from the Translating Research Into Action For Diabetes Study (Kerr et al., 2004) . Performed CRC screening was defined as documented colonoscopy in the last 10 years, flexible sigmoidoscopy, or doublecontrast barium enema in the last 5 years, or FOBT in the last 2 years, on the basis of the US Preventive Services Task Force (2002) (2005) (2006) . Patients who refused CRC screening (n = 22) were grouped with those not screened, even though screening was offered by the physician, as this information might not be systematically documented in medical charts and therefore not adequately captured by chart. To measure physicianinitiated care, we repeated the analysis categorizing these patients with the performed CRC screening group in a secondary analysis.
As chart abstraction might underestimate quality of care by 5-10% compared with clinical vignettes and standardized patients (Peabody et al., 2000) , inter-rater reliability was assessed by repeating the chart abstraction on a random sample of patients (n = 45) to detect a significant k value (Sim and Wright 2005; Collet et al., 2011) . For CRC screening, the k value was 0.85. Influenza immunization indicators were validated with an external administrative register at Lausanne, as reported previously (Collet et al., 2011) . For 230 patients, no BMI value could be abstracted or calculated from medical charts; we imputed these missing values using the Gaussian normal regression imputation method from known values of a patient's age, sex, weight, and height. We report the median, lower, and upper quartile of BMI before and after imputation, and the proportion of imputed BMI values for each BMI category. We categorized the age of the patients into three life decades, and categorized birthplace as Switzerland or foreign country, further divided into Western European and North American countries, defined as country in the child and adult mortality stratum A according to the Annex 1 of the WHO 2003 World Health Report (World Health Organization, 2003) , and outside of Western Europe and North America, mortality strata B-E. We dichotomized continuous variables without a normal distribution, that is Charlson combined age-comorbidity index, the number of prescribed medications, and the number of visits to the physician in charge, according to the median, and reported interquartile ranges.
Statistical analyses
We used descriptive statistics and bivariate analyses to characterize the sample, and performed multivariate logistical regression to analyze the predictors of adequate CRC screening. Results are reported as percentages with 95% binomial exact confidence intervals (CIs). To account for clustering within each of the four University settings, we treated each site as a fixed effect. Multivariate logistic regression analysis was repeated in sensitivity analyses using measured BMI without imputation and the number of prescribed medications in addition to the Charlson index. We used Stata software (version 12.1; Stata Corp., College Station, Texas, USA) for all statistical analyses. Table 1 shows the characteristics of the 940 patients included. The mean age of the patients was 63.9 years (SD 8.8), and 402 patients (42.7%) were women. The median BMI was 27.9 (lower quartile: 24.9, upper quartile: 31.2) before imputation and 28.2 kg/m 2 (interquartile range 24.8-32.1) after imputation. Most of the care was provided by residents (89.5 vs. 10.5% by senior residents or attending physicians) and 55.1% of patients were followed by female physicians. Annual influenza vaccination was provided to 22.3% of patients, whereas 77.7% did not receive vaccination. Table 2 shows the CRC screening rates and describes the screening methods. Only 316 (33.6%) patients eligible for CRC screening had received adequate CRC screening. Refusal of CRC screening was documented in 22 patients (2.3%). Fifty-five percent underwent a colonoscopy, 41.3% underwent FOBT alone or combined with endoscopy, and only 3.8% underwent flexible sigmoidoscopy alone. Double-contrast barium enema was not used for any patient.
Results
Patient description
Colorectal cancer screening rates
The results of bivariate and multivariate logistical regression analyses are reported in Table 3 . In bivariate analyses, being overweight (BMI 25.0-29.9 kg/m 2 ) and obese (BMI Z 30.0 kg/m 2 ) was associated with lower CRC screening rates [odds ratio (OR) 0.64, CI 0.46-0.90 and OR 0.61, CI 0.43-0.88, respectively; P for Physician in charge is defined as the physician the patient had the most visits to. Adjusted for age, sex, civil status, occupation, birthplace, BMI, Charlson combined age-comorbidity index, annual influenza vaccination, number of visits to the physician in charge, and function, sex and age of the physician in charge, using a multilevel generalized linear model and treating each site as a random effect. N = 897 because of missing values.
Discussion
We found that only about one in three patients followed up in Swiss University primary care settings were screened for CRC. This relatively low CRC screening rate is comparable with those reported in some underserved populations in the USA (Doubeni et al., 2012) . We found three characteristics to be associated with lower CRC screening rates: being overweight or obese, male sex of the physician in charge, and being born in a country outside of Western Europe and North America. None of the other measured sociodemographic factors (patient sex, occupation, civil status) or patient health status estimated by the Charlson combined age-comorbidity index reached statistical significance.
As hypothesized previously (Collet et al., 2011) , the absence of a population-based CRC screening program, or the lack of systematic performance monitoring in Switzerland, might explain these low CRC screening rates. This hypothesis is also supported by findings of a Canadian study, where higher CRC screening rates were found in regions with recent implementation of a CRC screening program (Sewitch et al., 2007) . Also, influenza vaccination has been shown to be associated with higher CRC screening rates (Zimmermann et al., 2006; Sewitch et al., 2007) , but was not significant in our study, possibly because of the small sample size.
The negative association between BMI and CRC screening has been reported in previous studies (Ferrante et al., 2006) , but a recent review article by Fagan et al. (2011b) showed a mixed pattern of association between weight status and CRC screening without a clear trend toward a positive or a negative association throughout the literature. The authors hypothesized that factors associated with CRC screening might differ according to the race and sex of the population studied. Overweight individuals might be less health conscious and therefore less demanding of healthcare. However, previous studies have shown that the lack of recommendation by the physician is the most frequent reason to skip CRC screening, instead of patients not asking or refusing it (Wee et al., 2005) . Also, physicians might have been less likely to recommend CRC screening to overweight and obese patients, either because they believe that these patients would not want screening or because of higher priority on other medical conditions. However, in the latter case, one would expect the same to be true for patients with a higher Charlson combined age-comorbidity index. This potential stigmatization of overweight and obese patients by their physicians has been documented (Wee et al., 2000; Sikorski et al., 2011) .
Female sex of the physician in charge has been associated with higher rates of screening mammographies and cervical smears (Lurie et al., 1993) . However, physician sex was not associated with CRC screening in previous studies (Wong et al., 2009) . Female physicians might be more sensitized to cancer prevention through their participation as patients in regional, population-based breast cancer screening programs in Switzerland, and well-implemented screening for cervical cancer, whereas no such program exists for cancer in men.
Our finding that CRC screening is associated with birthplace outside of Western Europe and North America is consistent with previous studies that found ethnicity to be associated with CRC screening (Wee et al., 2005; Zimmermann et al., 2006; Sewitch et al., 2007; Phillips et al., 2013) . These studies also found other sociodemographic factors such as sex and educational level to be predictors of CRC screening that did not reach statistical significance in our results. This might be because of the relatively small sample size. A recent review by Naylor et al. (2012) suggests that patient education and physician training in communication with patients of low health literacy are paths for improving adherence to CRC screening in ethnic minorities.
Our study has several limitations. A first limitation was the potential under-reporting in medical charts of data such as patient refusal of screening. Process-based quality scores using abstraction of medical charts have been found to underestimate the quality of care compared with clinical vignettes and standardized patients by 5 and 10%, respectively (Peabody et al., 2000) . Second, we considered any initial sigmoidoscopy in the last 5 years or colonoscopy in the last 10 years as CRC screening, because of lack of complete data on the indication, and excluded follow-up colonoscopies for CRC or adenomatous polyps only. We therefore cannot exclude that some of these endoscopic procedures were performed for symptomatic indications, such as rectal bleeding. Third, our results rely on imputed BMI and sensitivity analysis confirmed the association between CRC screening and obesity only, but not for overweight and physician sex. This might be because of loss of power in the statistical model (n = 688) and potential under-reporting of BMI in normal weight and overweight, but not for obese patients. Fourth, our sample in University primary care settings might not be representative of the general Swiss population. In fact, our sample had a high proportion of patients with a migratory background (51%) and men (57%), and a higher prevalence of obesity than in the general Swiss population (32% in our sample vs. 13% in the general Swiss population aged 55-74 years) (Schneider et al., 2009) . Our model was adjusted for these characteristics. Fifth, most of the care was provided by residents in postgraduate training. Similar to our study, a previous report on CRC screening showed no difference in screening rates between physicians with or without completed postgraduate training (Wong et al., 2009 ), but we did not find studies directly comparing screening rates between community-based primary care physicians and University-based residents within a healthcare system with universal coverage. Sixth, it was not possible to measure patient and physician knowledge and beliefs on CRC and CRC screening, as this study was based on a retrospective review of medical charts. Seventh, because of the relatively small sample size, the absence of statistical significance has to be interpreted with caution, as the study might not have enough power to detect associations in subgroups.
These results may be important for clinical practice, as obesity has been suggested to be a risk factor for CRC (Gunter and Leitzmann 2006; Liu et al., 2012) . Physician perception of obesity and its impact on their recommendation for CRC screening might be a target for further research. A population-based CRC screening program and a systematic performance monitoring might help improve the rate of CRC screening.
